GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (LTS:0NLV) » Definitions » Cyclically Adjusted Price-to-FCF

Vita 34 AG (LTS:0NLV) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vita 34 AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Vita 34 AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG Cyclically Adjusted Price-to-FCF Chart

Vita 34 AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.76 26.73 25.15 14.80 -

Vita 34 AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.80 10.27 8.54 - -

Competitive Comparison of Vita 34 AG's Cyclically Adjusted Price-to-FCF

For the Medical Care Facilities subindustry, Vita 34 AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita 34 AG's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vita 34 AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vita 34 AG's Cyclically Adjusted Price-to-FCF falls into.



Vita 34 AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Vita 34 AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Vita 34 AG's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.173/125.0381*125.0381
=0.173

Current CPI (Mar. 2024) = 125.0381.

Vita 34 AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.081 99.543 -0.102
201409 0.353 99.823 0.442
201412 -0.227 99.543 -0.285
201503 0.262 99.717 0.329
201506 -0.030 100.417 -0.037
201509 0.360 100.417 0.448
201512 0.055 99.717 0.069
201603 -0.091 100.017 -0.114
201606 -0.032 100.717 -0.040
201609 0.405 101.017 0.501
201612 0.278 101.217 0.343
201703 -0.070 101.417 -0.086
201706 -0.108 102.117 -0.132
201709 0.304 102.717 0.370
201712 0.074 102.617 0.090
201803 0.022 102.917 0.027
201806 0.271 104.017 0.326
201809 0.441 104.718 0.527
201812 0.181 104.217 0.217
201903 0.228 104.217 0.274
201906 0.235 105.718 0.278
201909 0.487 106.018 0.574
201912 0.361 105.818 0.427
202003 0.147 105.718 0.174
202006 0.237 106.618 0.278
202009 0.263 105.818 0.311
202012 0.059 105.518 0.070
202103 0.199 107.518 0.231
202106 0.111 108.486 0.128
202109 0.066 109.435 0.075
202112 -0.066 110.384 -0.075
202203 -0.047 113.968 -0.052
202206 -0.254 115.760 -0.274
202209 -0.008 118.818 -0.008
202212 -0.366 119.345 -0.383
202303 0.026 122.402 0.027
202306 0.010 123.140 0.010
202309 0.051 124.195 0.051
202312 0.209 123.773 0.211
202403 0.173 125.038 0.173

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vita 34 AG  (LTS:0NLV) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Vita 34 AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita 34 AG (LTS:0NLV) Business Description

Traded in Other Exchanges
Address
Deutscher Platz 5a, Leipzig, DEU, D-04103
Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.

Vita 34 AG (LTS:0NLV) Headlines

No Headlines